← FDA Drug Approvals (Drugs@FDA)

LEVETIRACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2022-07-15

Drug application

FDA Application #

ANDA214757

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVETIRACETAM

Generic name

LEVETIRACETAM

Active ingredients

LEVETIRACETAM

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

Manufacturer

Novadoz Pharmaceuticals LLC

First approval

2022-07-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown